Management of febrile neutropenia in an acute oncology service

QJM: An International Journal of Medicine

Volumn 105, Issue 4, 2012, Pages 327-336

  Sammut, S J ^a   Mazhar, D ^a  

^a CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GENTAMICIN; PIPERACILLIN PLUS TAZOBACTAM; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BLADDER CANCER; BREAST CANCER; CANCER CENTER; CLINICAL ARTICLE; CLINICAL ASSESSMENT; DIGESTIVE SYSTEM CANCER; ELECTRONIC MEDICAL RECORD; EMERGENCY WARD; FEBRILE NEUTROPENIA; FEMALE; HEALTH CARE QUALITY; HUMAN; LENGTH OF STAY; LUNG CANCER; MALE; NEUTROPHIL COUNT; OBSERVATIONAL STUDY; OUTPATIENT CARE; OUTPATIENT DEPARTMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SARCOMA; TESTIS CANCER; THORAX RADIOGRAPHY;

EID: 84859057522     PISSN: 14602725     EISSN: 14602393     Source Type: Journal    
DOI: 10.1093/qjmed/hcr217     Document Type: Article

References (16)

1. Schimpff S, Satterlee W, Young VM, Serpick A. Empiric therapy with carbenicillin and gentamicin for febrile patients with cancer and granulocytopenia. N Engl J Med 1971; 284:1061-5.
2. Kuderer NM, Dale DC, Crawford J, Cosler LE, Lyman GH. Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients. Cancer 2006; 106:2258-66.
3. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992; 101:1644-55.
4. Talcott JA, Siegel RD, Finberg R, Goldman L. Risk assessment in cancer patients with fever and neutropenia: a prospective, two-center validation of a prediction rule. J Clin Oncol 1992; 10:316-22.
5. Innes H, Lim SL, Hall A, Chan SY, Bhalla N, Marshall E. Management of febrile neutropenia in solid tumours and lymphomas using the Multinational Association for Supportive Care in Cancer (MASCC) risk index: feasibility and safety in routine clinical practice. Support Care Cancer 2008; 16:485-91.
6. NCEPOD. For better, for worse? A review of the care of patients who died within 30 days of receiving systemic anti-cancer therapy. UK, National Confidential Enquiry into Patient Outcome and Death, 2008.
7. NCAG. Chemotherapy Services in England: Ensuring quality and safety A Report from the National Chemotherapy Advisory Group. UK: Department of Health, 2009.
8. Clarke RT, Warnick J, Stretton K, Littlewood TJ. Improving the immediate management of neutropenic sepsis in the UK: lessons from a national audit. Br J Haematol 2011; 153:773-9.
9. Subbe CP. Better ViEWS ahead? It is high time to improve patient safety by standardizing Early Warning Scores. Resuscitation 2010; 81:923-4.
10. Gaieski DF, Mikkelsen ME, Band RA, Pines JM, Massone R, Furia FF, et al. Impact of time to antibiotics on survival in patients with severe sepsis or septic shock in whom early goal-directed therapy was initiated in the emergency department. Crit Care Med 2010; 38:1045-53.
11. Innes H, Billingham L, Gaunt C, Steven N, Marshall E. Management of febrile neutropenia in the United Kingdom: time for a national trial? Br J Cancer 2005; 93:1324-8.
12. Hughes WT, Armstrong D, Bodey GP, Bow EJ, Brown AE, Calandra T, et al. 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 2002; 34:730-51.
13. Klastersky J, Paesmans M, Rubenstein EB, Boyer M, Elting L, Feld R, et al. The Multinational Association for Supportive Care in Cancer risk index: a multinational scoring system for identifying low-risk febrile neutropenic cancer patients. J Clin Oncol 2000; 18:3038-51.
14. Department of Health. Reforming emergency care: first steps to a new approach. London: HMSO, 2001.
15. Guly H, Higginson I. Obituary for the four-hour target. Emerg Med J 2011; 28:179-80.
16. Okera M, Chan S, Dernede U, Larkin J, Popat S, Gilbert D, et al. A prospective study of chemotherapy-induced febrile neutropenia in the South West London Cancer Network. Interpretation of study results in light of NCAG/NCEPOD findings. Br J Cancer 2011; 104:407-12.